New Breakthrough Devices Program Guidance: Expanding Opportunities for Medical Product Innovations
FDA Law Blog
OCTOBER 17, 2023
FDA previously released the final guidance document in December 2018 outlining the program’s principles, features, designation criteria, and other considerations. Additionally, the 2022 draft guidance suggested the addition of a new section to the 2018 guidance on reducing disparities in health and healthcare.
Let's personalize your content